[go: up one dir, main page]

WO2009072576A1 - Stimulateur de la formation osseuse - Google Patents

Stimulateur de la formation osseuse Download PDF

Info

Publication number
WO2009072576A1
WO2009072576A1 PCT/JP2008/072083 JP2008072083W WO2009072576A1 WO 2009072576 A1 WO2009072576 A1 WO 2009072576A1 JP 2008072083 W JP2008072083 W JP 2008072083W WO 2009072576 A1 WO2009072576 A1 WO 2009072576A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
bone formation
formation stimulator
stimulator
beverage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/072083
Other languages
English (en)
Japanese (ja)
Inventor
Jun Fuchimoto
Yukio Okada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sapporo Breweries Ltd
Original Assignee
Sapporo Breweries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sapporo Breweries Ltd filed Critical Sapporo Breweries Ltd
Priority to JP2009544718A priority Critical patent/JPWO2009072576A1/ja
Publication of WO2009072576A1 publication Critical patent/WO2009072576A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne un nouveau stimulateur de la formation osseuse comprenant au moins un composant choisi dans le groupe constitué par un acide alpha, un acide isoalpha, un acide tétrahydroisoalpha, un acide rhoisoalpha et un acide hexahydroisoalpha comme principe actif. L'invention concerne également une préparation médicinale, un additif pour aliment ou boisson, un aliment, une boisson, un additif alimentaire, un aliment pour animaux ou similaire comprenant le stimulateur de la formation osseuse.
PCT/JP2008/072083 2007-12-04 2008-12-04 Stimulateur de la formation osseuse Ceased WO2009072576A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009544718A JPWO2009072576A1 (ja) 2007-12-04 2008-12-04 骨形成促進剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007313890 2007-12-04
JP2007-313890 2007-12-04

Publications (1)

Publication Number Publication Date
WO2009072576A1 true WO2009072576A1 (fr) 2009-06-11

Family

ID=40717753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/072083 Ceased WO2009072576A1 (fr) 2007-12-04 2008-12-04 Stimulateur de la formation osseuse

Country Status (2)

Country Link
JP (1) JPWO2009072576A1 (fr)
WO (1) WO2009072576A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018131389A (ja) * 2017-02-13 2018-08-23 サッポロホールディングス株式会社 アセトアルデヒドデヒドロゲナーゼ活性促進剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用
JPH07330594A (ja) * 1994-04-12 1995-12-19 Hoechst Japan Ltd 骨粗鬆症治療剤
WO2003068205A1 (fr) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions et aliments ameliorant le metabolisme des lipides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE485270T1 (de) * 2006-07-25 2010-11-15 Sanofi Aventis 2-phenylindole als antagonisten des prostaglandin-d2-rezeptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用
JPH07330594A (ja) * 1994-04-12 1995-12-19 Hoechst Japan Ltd 骨粗鬆症治療剤
WO2003068205A1 (fr) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions et aliments ameliorant le metabolisme des lipides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018131389A (ja) * 2017-02-13 2018-08-23 サッポロホールディングス株式会社 アセトアルデヒドデヒドロゲナーゼ活性促進剤

Also Published As

Publication number Publication date
JPWO2009072576A1 (ja) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2006096434A3 (fr) Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
EP4512399A3 (fr) Formes à l'état solide de tafamidis et leurs sels
WO2007090393A3 (fr) Préparation pharmaceutique
WO2008088030A1 (fr) Composition destinée à la prévention ou au traitement d'une maladie associée à un thrombus ou à un embole
WO2010049454A3 (fr) Composition antimicrobienne tirée de copépodes
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2007045252A3 (fr) Composition comestible
WO2011090270A3 (fr) Composition contenant de l'osmotine pour prévenir et traiter des troubles neurologiques
MX2009012010A (es) Composiciones de vegetal o fruta aireadas, liofilizadas y metodos para elaboracion de las mismas.
WO2012091440A3 (fr) Composition pour l'amélioration, le traitement et la prévention de troubles de la motilité du tractus gastro-intestinal
WO2010087565A3 (fr) Nouvelle utilisation de la pipérine
EP4327880A3 (fr) Forme à l'état solide de succinate de ribociclib
WO2011059292A3 (fr) Concentré ou extrait de pousse d'aloès officinal favorisant fortement la croissance des cellules cutanées et présentant des effets anti-allergiques et antioxydants supérieurs
WO2008027600A3 (fr) Compositions d'imatinib
WO2008155998A1 (fr) Agent tranquillisant/antidépresseur
WO2007044950A3 (fr) Formes cristallines de docetaxel et leurs processus de preparation
WO2008088779A3 (fr) Formes solides de 5-azacytidine et procédés de préparation de ces dernières
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2011043631A3 (fr) Composition pharmaceutique pour la prévention et le traitement du rhume, contenant un extrait de reynoutria elliptica, une fraction de celui-ci ou un composé à base de stilbène
WO2010127787A3 (fr) Combinaisons d'agents actifs ayant des propriétés insecticides et acaricides
WO2009025792A3 (fr) Formes cristallines de cinacalcet fumarate et de cinacalcet succinate et leurs procédés de préparation
WO2011106630A3 (fr) Composés antimicrobiens de chrysophanéine inhibant la protéine ftsz

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08857164

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009544718

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08857164

Country of ref document: EP

Kind code of ref document: A1